The 5 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +79.49% increase from the last price of 3.90.
The current consensus among 5 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.31
Reporting Date Mar 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.